Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
about
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.Darunavir for Use in Pregnant Women with HIV.Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.
P2860
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
@en
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
@nl
type
label
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
@en
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
@nl
prefLabel
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
@en
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
@nl
P2093
P2860
P356
P1433
P1476
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
@en
P2093
C Zorrilla
H M Crauwels
O O Osiyemi
P Verboven
V Hillewaert
P2860
P304
P356
10.1111/HIV.12366
P577
2016-05-17T00:00:00Z